CERo Therapeutics Holdings, Inc. (CERO)
NASDAQ: CERO · IEX Real-Time Price · USD
3.070
+1.440 (88.34%)
At close: Mar 28, 2024, 4:00 PM
3.300
+0.230 (7.49%)
After-hours: Mar 28, 2024, 7:12 PM EDT

CERO Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20222021
Selling, General & Admin
2.132.48
Research & Development
9.859.14
Operating Expenses
11.9711.62
Operating Income
-11.97-11.62
Other Expense / Income
-0.14-0.99
Pretax Income
-11.83-10.63
Net Income
-11.83-10.63
Shares Outstanding (Basic)
99
Shares Outstanding (Diluted)
99
Shares Change
-0.08%-
EPS (Basic)
-1.32-1.18
EPS (Diluted)
-1.32-1.18
Free Cash Flow
-12.4-10.71
Free Cash Flow Per Share
-1.38-1.19
EBITDA
-10.76-9.89
Depreciation & Amortization
1.070.74
EBIT
-11.83-10.63
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).